| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Technical Officer
1 company
Guyer Charles Greg is an EVP, Chief Technical Officer at BMRN. Recent filings cover 0 purchases and 5 sales. Those positions are worth an estimated $4.7M at current prices.
Our model assigns Guyer Charles Greg a strong insider score of 70/100, based on 5 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +10.4%.
Guyer Charles Greg's largest disclosed position is in BMRN as EVP, Chief Technical Officer, worth about $4.7M. The recent filings there lean toward selling, a net 40,363 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | BMRN Biomarin Pharmaceutical Inc. | EVP, Chief Technical Officer | Sell | 16,486 | $60.46 | $996,743.56 | -17.1% | -4.0% | - | |
| Mar 6, 2025 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Technical Officer | Sell | 7,034 | $71.28 | $501,355.38 | -7.4% | -21.2% | -14.2% | |
| Nov 12, 2024 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Technical Officer | Sell | 5,278 | $66.37 | $350,323.56 | -7.1% | -4.0% | -16.3% | |
| Aug 9, 2023 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Technical Officer | Sell | 5,360 | $93.30 | $500,109.44 | -11.8% | -8.3% | -5.7% | |
| Aug 8, 2022 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Technical Officer | Sell | 6,205 | $96.56 | $599,154.80 | -12.8% | -15.0% | -5.3% |